Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation

American Journal of Transplantation

Volumn 10, Issue 9, 2010, Pages 2033-2042

  Bartel, G ^a   Wahrmann, M ^a   Regele, H ^b   Kikic Z ^a   Fischer, G ^b   Druml, W ^a   Muhlbacher F ^b   Bohmig G A ^a  

^a Division of Nephrology and Dialysis   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allosensitization; antibody mediated rejection; desensitization; immunoadsorption; kidney transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN A; TACROLIMUS;

ADULT; ALLOIMMUNITY; APHERESIS; ARTICLE; BLOOD GROUP TYPING; COMPLEMENT DEPENDENT CYTOTOXICITY; DESENSITIZATION; DONOR SELECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

ADOLESCENT; ADULT; BLOOD GROUPING AND CROSSMATCHING; CADAVER; COHORT STUDIES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956136574     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03226.x     Document Type: Article

References (49)

1. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003 3 : 665 673.
2. Claas FH, Doxiadis, II. Management of the highly sensitized patient. Curr Opin Immunol 2009 21 : 569 572.
3. Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000 70 : 887 895.
4. Schweitzer EJ, Wilson JS, Fernandez-Vina M et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000 70 : 1531 1536.
5. Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002 2 : 758 760.
6. Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003 3 : 1017 1023.
7. Higgins R, Hathaway M, Lowe D et al. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: Resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007 84 : 876 884.
8. Magee CC, Felgueiras J, Tinckam K et al. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: One center's experience. Transplantation 2008 86 : 96 103.
9. Vo AA, Lukovsky M, Toyoda M et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008 359 : 242 251.
10. Thielke JJ, West-Thielke PM, Herren HL et al. Living donor kidney transplantation across positive crossmatch: The University of Illinois at Chicago experience. Transplantation 2009 87 : 268 273.
11. Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Am J Transplant 2010 10 : 449 457.
12. Jordan SC, Tyan D, Stablein D et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial. J Am Soc Nephrol 2004 15 : 3256 3262.
13. Higgins RM, Bevan DJ, Carey BS et al. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation. Lancet 1996 348 : 1208 1211.
14. Lorenz M, Regele H, Schillinger M et al. Peritransplant immunoadsorption: A strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients. Transplantation 2005 79 : 696 701.
15. Beimler JH, Morath C, Schmidt J et al. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab. Transplantation 2009 87 : 668 671.
16. Claas FH, Rahmel A, Doxiadis, II. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation 2009 88 : 447 452.
17. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964 204 : 998 1000.
18. Wahrmann M, Bartel G, Exner M et al. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 2009 22 : 982 989.
19. Claas FH, Doxiadis, II. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant. Hum Immunol 2009 70 : 636 639.
20. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723.
21. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008 8 : 753 760.
22. Böhmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002 13 : 1091 1099.
23. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969 280 : 735 739.
24. Tyden G, Kumlien G, Efvergren M. Present techniques for antibody removal. Transplantation 2007 84 (12 Suppl S27 S29.
25. Böhmig GA, Regele H, Exner M et al. C4d-positive acute humoral renal allograft rejection: Effective treatment by immunoadsorption. J Am Soc Nephrol 2001 12 : 2482 2489.
26. Böhmig GA, Wahrmann M, Regele H et al. Immunoadsorption in severe C4d-positive acute kidney allograft rejection: A randomized controlled trial. Am J Transplant 2007 7 : 117 121.
27. Shah A, Nadasdy T, Arend L et al. Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation 2004 77 : 1399 1405.
28. Zand MS, Vo T, Huggins J et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005 79 : 1507 1515.
29. Kushihata F, Watanabe J, Mulder A, Claas F, Scornik JC. Human leukocyte antigen antibodies and human complement activation: Role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004 78 : 995 1001.
30. Bartel G, Wahrmann M, Exner M et al. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 2007 83 : 727 733.
31. Burns JM, Cornell LD, Perry DK et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008 8 : 2684 2694.
32. Martin L, Guignier F, Mousson C et al. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003 76 : 395 400.
33. Heinemann FM, Roth I, Rebmann V et al. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts. Hum Immunol 2007 68 : 500 506.
34. Suberbielle C, Legendre C, Chkoff N et al. Anti-HLA sensitization after renal transplant excision: A retrospective study in 84 patients. Transplant Proc 1996 28 : 2814.
35. Adeyi OA, Girnita AL, Howe J et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 2005 14 : 53 62.
36. Zachary AA, Montgomery RA, Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 2003 76 : 1519 1525.
37. Salama AD, Delikouras A, Pusey CD et al. Transplant accommodation in highly sensitized patients: A potential role for Bcl-xL and alloantibody. Am J Transplant 2001 1 : 260 269.
38. Gloor JM, Cosio FG, Rea DJ et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006 6 : 1841 1847.
39. Haas M, Segev DL, Racusen LC et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2009 20 : 197 204.
40. Bartel G, Regele H, Wahrmann M et al. Posttransplant HLA alloreactivity in stable kidney transplant recipients-incidences and impact on long-term allograft outcomes. Am J Transplant 2008 8 : 2652 2660.
41. Park WD, Grande JP, Ninova D et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003 3 : 952 960.
42. Tang AH, Platt JL. Accommodation of grafts: Implications for health and disease. Hum Immunol 2007 68 : 645 651.
43. Haas M, Rahman MH, Racusen LC et al. C4d and C3d staining in biopsies of ABO-and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant 2006 6 : 1829 1840.
44. Kraus ES, Parekh RS, Oberai P et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: Incidence and correlations. Am J Transplant 2009 9 : 1826 1834.
45. Lorenz M, Regele H, Schillinger M et al. Risk factors for capillary C4d deposition in kidney allografts: Evaluation of a large study cohort. Transplantation 2004 78 : 447 452.
46. Sis B, Jhangri GS, Bunnag S et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009 9 : 2312 2323.
47. Gibney EM, Cagle LR, Freed B et al. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006 21 : 2625 2629.
48. Reinsmoen NL, Lai CH, Vo A et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 2008 86 : 820 825.
49. Amico P, Honger G, Mayr M et al. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009 87 : 1681 1688.